Overview
Portfolio
More
Endurance28
San Francisco, United States
Early‑stage venture capital focused on empowering entrepreneurs tackling climate, health, and digital economy challenges, seeking opportunities where others are not looking.
Portfolio
34+
Employees
10+
Founded
2013
AUM
≈ $13.8M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
MexicoUnited States
Fund details
Funds
Fund II
Vintage 2020 • $0.0
Fund III
Vintage 2022 • $0.0
SVLC Healthco II LP
$2.1M
SVLC Fund III LP
$6.0M
SVLC IV LP
$800.0K
SVLC III LP
$3.4M
SVLC II LP
$1.5M
SV Latam Fund II LP
$0.0
Sources
Endurance28
Early‑stage venture capital focused on empowering entrepreneurs tackling climate, health, and digital economy challenges, seeking opportunities where others are not looking.
Portfolio
34+
Employees
10+
Founded
2013
AUM
≈ $13.8M
Funds
Fund II · Vintage 2020 • $0.0
Fund III · Vintage 2022 • $0.0
SVLC Healthco II LP · $2.1M
SVLC Fund III LP · $6.0M
SVLC IV LP · $800.0K
SVLC III LP · $3.4M
SVLC II LP · $1.5M
SV Latam Fund II LP · $0.0
Stages
No stages listed
Industries
No industries listedGeographic scope
MexicoUnited States
Sources
Showing 23 of 23 matched portfolio companies
Ares develops AI-enabled optical polymers using proprietary chemistry and machine learning to create advanced films and coatings for next-generation display devices. Their technology addresses the need for environmentally friendly materials in mobile, automotive, and transparent display applications, enhancing performance and sustainability.
Funding: $13.0M
Rough estimate of the amount of funding raised
Funding: $13.0M
Rough estimate of the amount of funding raised
Biomakers operates a centralized precision oncology platform that combines large‑scale genomic testing, clinical data aggregation, biobanking, and AI‑driven analytics across 18 Latin American countries. The integrated workflow delivers high‑quality molecular test results and tumor specimen storage, providing clinicians with actionable treatment insights and life‑science partners with diverse, real‑world genomic datasets to accelerate drug and diagnostic development.
Funding: $2.4M
Rough estimate of the amount of funding raised
Funding: $2.4M
Rough estimate of the amount of funding raised
Provides a no-code data automation platform that enables non-technical business teams to import, transform, and visualize large datasets without relying on spreadsheets or coding. This streamlines workflows in areas like financial services, internal audit, and business operations, reducing manual effort and improving efficiency in data-driven decision-making.
Funding: $10.3M
Rough estimate of the amount of funding raised
Funding: $10.3M
Rough estimate of the amount of funding raised
The startup develops plug-and-play technology for e-bikes that facilitates the seamless integration of electric drive systems into existing bicycle designs. This technology enables traditional bicycles to be enhanced with electric capabilities without the need for extensive modifications or specialized technical skills.
Funding: $2.8M
Rough estimate of the amount of funding raised
Funding: $2.8M
Rough estimate of the amount of funding raised
Cubbo provides a logistics platform that automates e-commerce order fulfillment for direct-to-consumer brands in Latin America, ensuring rapid delivery and cost-effective shipping. By integrating with multiple sales channels and offering weekend operations, Cubbo enhances customer satisfaction and reduces operational complexities for its clients.
Funding: $10.8M
Rough estimate of the amount of funding raised
Funding: $10.8M
Rough estimate of the amount of funding raised
DIA provides a decentralized oracle platform that utilizes a rollup architecture to deliver real-time, verifiable data across over 50 blockchain networks, supporting more than 20,000 assets. This technology addresses the need for reliable and transparent data feeds in decentralized applications, enabling developers to integrate accurate price information without relying on third-party sources.
Funding: $50.0K
Rough estimate of the amount of funding raised
Funding: $50.0K
Rough estimate of the amount of funding raised
Encellin has developed a thin-film cell encapsulation device for Encapsulated Cell Replacement Therapy (EnCRT), enabling enclosed cells to function as therapeutic factories within the body. This technology addresses the issue of cell loss and dysfunction in endocrine disorders, particularly in type 1 diabetes, by providing a minimally invasive implant that delivers sustained therapeutic effects.
Develops pharmacological agents that stimulate mitochondrial thermogenesis, activating calorie-burning processes previously inhibited by modern living conditions. This approach targets metabolic disorders, including obesity, by providing a drug-based solution for sustained weight loss and improved metabolic health.
Funding: $650.0K
Rough estimate of the amount of funding raised
Funding: $650.0K
Rough estimate of the amount of funding raised
Fiado provides a Spanish‑language, FDIC‑insured prepaid Mastercard® for legal U.S. residents with no minimum balance requirement. The card supports direct‑deposit payroll, cash reloads at GreenDot® locations, contactless mobile‑wallet payments, domestic transfers, and real‑time remittances to family in Mexico, all backed by Spanish‑speaking customer support.
Founda Health develops software solutions for healthcare providers that facilitate seamless application integration and secure data exchange across electronic health records (EHRs). By automating patient registration and follow-up processes, Founda significantly reduces administrative burdens and enhances patient outcomes, saving healthcare staff over 400 hours annually.
Funding: $15.0M
Rough estimate of the amount of funding raised
Funding: $15.0M
Rough estimate of the amount of funding raised
GEn1E is a clinical-stage company utilizing a multi-target AI platform to develop first-in-class immunomodulators that specifically target kinase dysregulation in rare inflammatory diseases. Their approach employs novel allosteric binding mechanisms to enhance therapeutic specificity while minimizing off-target effects and toxicity associated with traditional kinase inhibitors.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
Genvision utilizes AI to analyze satellite imagery for measuring CO2 removal in nature-based carbon credit projects. The platform centralizes project data and provides tools for yield forecasting and project comparison, enabling investors to make informed decisions in the carbon market.
Funding: $1.1M
Rough estimate of the amount of funding raised
Funding: $1.1M
Rough estimate of the amount of funding raised
Dig is a social video intelligence platform that provides comprehensive global coverage of social video content. It decodes in-video elements like spoken words and visuals to surface emerging narratives and track brand perception at scale. This allows brands to proactively manage reputation, extract consumer insights, and optimize content strategy through real-time reporting and alerts.
Funding: $8.0M
Rough estimate of the amount of funding raised
Funding: $8.0M
Rough estimate of the amount of funding raised
Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.
Holoclara develops immunotherapy treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief for millions suffering from debilitating diseases by targeting the underlying immune responses associated with these conditions.
Funding: $21.7M
Rough estimate of the amount of funding raised
Funding: $21.7M
Rough estimate of the amount of funding raised
Justo provides restaurants in Latin America with a comprehensive e-commerce platform that enables direct online ordering, inventory management, and real-time reservation control. This technology enhances operational efficiency and increases profit margins by eliminating reliance on third-party delivery services.
Funding: $2.6M
Rough estimate of the amount of funding raised
Funding: $2.6M
Rough estimate of the amount of funding raised
Mate is a collaboration platform that connects established creators with emerging talent, allowing them to co-create content while automating revenue sharing from their projects. This addresses the challenge of visibility for new creators and provides a structured way for popular creators to invest in and nurture the next generation of artists.
Om provides access to massive, internally generated datasets detailing proteome-wide small molecule binding data. Researchers can programmatically query billions of protein and small molecule interaction data points to identify therapeutic opportunities instantly. The platform leverages synthetic biology and pico-scale engineering to accelerate the transition from hypothesis to launching a discovery program.
Funding: $250.0K
Rough estimate of the amount of funding raised
Funding: $250.0K
Rough estimate of the amount of funding raised
Oncoliq develops a liquid biopsy method utilizing microRNA detection for the early diagnosis of breast, prostate, and other cancers through a simple blood test. This technology addresses the critical issue of late cancer detection, aiming to identify up to 50 types of cancer, thereby significantly improving treatment outcomes and reducing mortality rates.
Funding: $840.0K
Rough estimate of the amount of funding raised
Funding: $840.0K
Rough estimate of the amount of funding raised
Prixz is an online pharmacy that provides a wide range of medications, vitamins, and health products, ensuring easy access to essential health resources across Mexico. By leveraging a robust logistics network, Prixz addresses the challenge of medication availability and delivery efficiency, allowing customers to receive their prescriptions and health products quickly and reliably.
Funding: $9.2M
Rough estimate of the amount of funding raised
Funding: $9.2M
Rough estimate of the amount of funding raised
Protein Technologies Intl specializes in developing protein-based solutions for applications in the biotechnology sector, utilizing advanced extraction and purification techniques. The company addresses the need for sustainable and efficient protein sources in various industries, enhancing product quality and reducing reliance on traditional animal-based proteins.
Safi Biotherapeutics specializes in the scalable ex vivo manufacturing of tailored red blood cells for acute and chronic transfusions, addressing critical shortages in blood supply. Their technology enables on-demand production of blood products, ensuring high consistency and economic viability for specific medical needs, such as trauma care and sickle cell disease transfusions.
Torch Sensors provides an AI-powered sensor network for ultra-early wildfire detection, capable of identifying flames within an average of three minutes across large land areas. This technology enables communities and enterprises to mitigate fire damage and reduce insurance liabilities by delivering actionable insights and timely alerts.
Showing 11 of 11 unmatched portfolio companies
GIRA
No website provided
We don't have a full profile for this company yet.
SKYALERT
No website provided
We don't have a full profile for this company yet.
COMBINATI
No website provided
We don't have a full profile for this company yet.
FINLESS FOODS
No website provided
We don't have a full profile for this company yet.
MICRO MEAT
No website provided
We don't have a full profile for this company yet.
BIOZ
No website provided
We don't have a full profile for this company yet.
CORRELIA BIOSYSTEMS
No website provided
We don't have a full profile for this company yet.
MUSA
No website provided
We don't have a full profile for this company yet.
WELBE
No website provided
We don't have a full profile for this company yet.
NEBIA
No website provided
We don't have a full profile for this company yet.
MERCÊ DO BAIRRO
No website provided
We don't have a full profile for this company yet.